Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Yinghong Wang, MD, PhD, MS
Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang. Dr. Wang is a Professor in the Department of Gastroenterology, Hepatology, and Nutrition at MD Anderson Cancer Center in Houston, Texas, as well as Director of the Oncology-GI Toxicity Program, Director of Fecal Microbiota Transplantation, Deputy Division Head of Research in the Division of Internal Medicine, and Chair of the MD Anderson Cancer Center Immunotherapy Toxicity Working Group.
-------- Â
--------
Exploring Technological Advances in GI Training: Practical Insights for Clinicians
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Nabil Mansour, MD
Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy training while preserving core competencies. Dr. Mansour is an Associate Professor and the Director of the McNair General GI Clinic at Baylor College of Medicine in Houston.
-------- Â
--------
Best Practices for Assessing Minimally Elevated Liver Tests
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Kwo, MD
While sometimes overlooked, minimally elevated liver tests may signal early liver disease or non-hepatic conditions like thyroid dysfunction. As a result, interpreting ALT and AST thresholds, assessing metabolic risk, and reviewing lifestyle factors can help shape a focused diagnostic approach and reduce liver-related complications. Joining Dr. Peter Buch to provide insights into the evaluation of minimally elevated liver tests is Dr. Paul Kwo, who’s a Professor of Medicine and Director of Hepatology at Stanford University.
-------- Â
--------
Preventive Care Essentials for Patients with IBD: Reviewing ACG Guideline Updates
Guest: Francis Farraye, MD
Host: Peter Buch, MD, FACG, AGAF, FACP
A 2025 update to the American College of Gastroenterology (ACG)'s guideline on preventive care in inflammatory bowel disease (IBD) includes key changes impacting vaccine recommendations, dermatologic screening, and care coordination. Dr. Peter Buch sits down with Dr. Francis Farraye, lead author of this guideline, to highlight what clinicians need to know. Dr. Farraye is a Professor of Medicine and the Director of the Inflammatory Bowel Disease Center at the Mayo Clinic in Jacksonville, Florida
-------- Â
--------
Reimagining GI Care: Digital Therapeutics for Managing IBS and IBD Symptoms
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Iris Wang, M.D.
From symptom trackers to multidisciplinary app-based platforms, evidence-based digital therapeutics are expanding access to brain-gut behavioral care for patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Dr. Peter Buch sits down with Dr. Iris Wang to discuss the spectrum of available tools and explore strategies for aligning them with individual patient needs. Dr. Wang is an Associate Professor of Medicine and the Associate Program Director of the Gastroenterology Fellowship at the Mayo Clinic in Rochester, Minnesota.
Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.
South Africa